探索伪化:疾病中的失调和治疗潜力
Maria Guillen-Angel1, Jean-Yves Roignant2
1Center for Integrative Genomics, Faculty of Biology and Medicine, University of Lausanne, 1015 Lausanne, Switzerland.
Current opinion in genetics & development
|June 4, 2024
概括
在RNA中的伪尤里丁 (Ψ) 修饰对于细胞功能至关重要. 伪尿的变化与疾病有关,但 Ψ 也具有治疗潜力,如COVID-19疫苗和遗传疾病治疗中所见.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 伪尤里丁 (Ψ) 是最丰富的RNA修饰物.
- Ψ影响了mRNA前拼接,RNA稳定性和蛋白质翻译.
- 伪尿的失调与各种人类疾病有关.
研究的目的:
- 审查最近对人类疾病中RNA伪化变化的洞察力.
- 探索 Ψ. 的治疗潜力.
- 讨论 Ψ 在神经发育疾病和癌症中的作用.
主要方法:
- 对近期关于伪尿化研究的文献综述.
- 对降低 Ψ 水平对 RNA 处理和翻译的影响进行分析.
- 检查 Ψ. 的治疗应用.
主要成果:
- 减少RNA中的 Ψ水平会影响RNA处理和蛋白质翻译.
- 伪尿化变化与神经发育疾病和癌症有关.
- N1-甲基-Ψ mRNA 疫苗在抗击 COVID-19 方面取得了成功.
- 针对遗传性疾病,正在开发RNA引导的伪化酶.
结论:
- RNA伪化在人类健康和疾病中起着重要作用.
- Ψ修饰为各种疾病提供了有前途的治疗策略,包括传染病和遗传疾病.
更多相关视频
07:05Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay
Published on: September 27, 2024
441
09:59Investigation of RNA Synthesis Using 5-Bromouridine Labelling and Immunoprecipitation
Published on: May 3, 2018
9.5K
相关概念视频
RNA Editing
9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Translation
14.8K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
14.8K
The Unfolded Protein Response
4.5K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.5K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
